4.6 Article

Cutting edge: MHC class II-restricted killing in vivo during viral infection

Journal

JOURNAL OF IMMUNOLOGY
Volume 174, Issue 2, Pages 614-618

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.174.2.614

Keywords

-

Categories

Funding

  1. NCI NIH HHS [CA34461] Funding Source: Medline
  2. NIAID NIH HHS [AI17672, AI07439] Funding Source: Medline
  3. NIAMS NIH HHS [AR35506] Funding Source: Medline

Ask authors/readers for more resources

Class II-restricted CD4 T cell-mediated killing of target cells has previously been documented in vitro but not in vivo. In this study, we demonstrate CD4-dependent MHC class II-restricted killing in lymphocytic choriomeningitis virus-infected mice in vivo using an in vivo cytotoxicity assay that features class II-expressing B cells as targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available